Misinformation is an urgent new problem, so health professions communities need solutions as much as they need to be wary of ethical pitfalls of rushed interventions.

During the COVID-19 pandemic, clinician policy makers have faced unprecedented challenges to their roles in governance.

Clinicians using governing authority to make public health policy are ethically obliged to draw upon scientific and clinical information that accords professional standards.

Spread of health misinformation by health professionals who also hold government positions represents a long-standing problem exacerbated during the COVID-19 pandemic.

When regulatory decisions express overconfidence, one risk is that the costliness or misinformation will exacerbate health inequity.

Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences.

Las debilidades en los enfoques regulatorios ante afirmaciones tergiversadas negligentes sobre suplementos dietéticos pueden tener consecuencias clínicas y de salud pública.